Anemia due to myelodysplastic syndrome

Anemia due to myelodysplastic syndrome is a hematologic complication characterized by a clinically significant deficiency of mature red blood cells and hemoglobin resulting from an underlying clonal hematopoietic stem cell disorder

Anemia due to myelodysplastic syndrome is a hematologic complication characterized by a clinically significant deficiency of mature red blood cells and hemoglobin resulting from an underlying clonal hematopoietic stem cell disorder

Predominantly affecting older adults, it arises within the bone marrow due to ineffective erythropoiesis accompanied by cellular dysplasia and premature apoptotic death of erythroid precursors

Predominantly affecting older adults, it arises within the bone marrow due to ineffective erythropoiesis accompanied by cellular dysplasia and premature apoptotic death of erythroid precursors Patients typically present with symptoms of reduced oxygen delivery, such as profound fatigue, weakness, and exertional dyspnea The condition frequently manifests as a macrocytic or normocytic anemia and, without disease-directed intervention, often leads to chronic transfusion dependence with an associate...

The condition frequently manifests as a macrocytic or normocytic anemia and, without disease-directed intervention, often leads to chronic transfusion dependence with an associated risk of secondary iron overload

The condition frequently manifests as a macrocytic or normocytic anemia and, without disease-directed intervention, often leads to chronic transfusion dependence with an associated risk of secondary iron overload